glp-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome UC Davis Health examines systemic

glp-1-based therapies

glp-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome UC Davis Health examines systemic

Name: glp-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome UC Davis Health examines systemic
Brand: www.marmorest.com
SKU: 15815596575
Price: 20.43 USD
Availability: InStock
Rating: 4.5742 (21 reviews)

SKU: 15815596575

4.6

EUR20.43 EUR61.43

Pay in 4 interest-free payments of $5.11 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

Hosseinzadeh H, Tafaghodi M, Mosavi MJ, Taghiabadi E

Osmolalidad apropiada : Las soluciones hipotnicas o isotnicas se absorben ms eficientemente que las hipertnicas, que pueden empeorar la diarrea, segn principios establecidos para soluciones de rehidratacin oral

bottom quartile with an OR of 1.24 (p for trend 0.33), but the 95% CI from 0.73 to 2.09 was wide and also included the null-effect values (Supplemental Table 2)